Reticular T1 Hypointensity at Hepatocellular Phase Gd-EOB-DTPA Enhanced MR Imaging: A Non-Invasive Sign of Oxaliplatin Induced Hepatic Toxicity

Keywords

abnormal abnormality accepted acknowledgments agent alanine alert anti appearance appearances arrow arterial available blue cancer cause chemotherapeutic chemotherapy classified clinical cohort combined complication complications concomitant confident confirmed congestion contraindications contrast corroborated criteria delayed describe describing developed developing diagnosis diffuse diffused diffusion dilatation disease dose dynamic either elevated enhanced entity establishing excluded features fibrosis findings frequency fulfilled function funding furthermore henry hepatic histology hospital identification identified implication inclusion induced institute intensity invasive involvement khan kingdom knowledge known leach lead leading liver lobe managing martin materials medium metastases metastatic modify months morbidity mortality none obstruction oncology opportunity oppose pathological pathologically patient patients pattern persistence phosphatase physician platinum post prevalence prior proven radiological radiologist radiology receive received receiving recognized recorded reduce regimes relate related resection reticular retrospectively revealed reviewed risk royal segmental series serum sign sinusoidal specimens square supported surgery surgical surrey syndrome system thereby toxicity treated treatment unclear underwent viii visible year years